{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:49:22Z","timestamp":1790790562826,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ygyno.2007.09.003","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T07:17:19Z","timestamp":1193210239000},"page":"136-140","source":"Crossref","is-referenced-by-count":41,"title":["Ovarian carcinosarcomas: Clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum"],"prefix":"10.1016","volume":"108","author":[{"given":"Irfan","family":"Cicin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Saip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Eralp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Selam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samet","family":"Topuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Ozluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucel","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Topuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2007.09.003_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1525-1438.2006.00760.x","article-title":"Current management of ovarian carcinosarcoma","volume":"17","author":"Mano","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2007.09.003_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/01.pgp.0000092134.88121.56","article-title":"Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis","volume":"22","author":"Jin","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cncr.20256","article-title":"Carcinosarcoma of the ovary: 19\u00a0years of prospective data from a single center","volume":"100","author":"Brown","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2007.09.003_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0090-8258(84)90039-8","article-title":"A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: a Gynecologic Oncology Group study","volume":"18","author":"Morrow","year":"1984","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0090-8258(89)80038-1","article-title":"Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas","volume":"32","author":"Terada","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib6","first-page":"660","article-title":"Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases","volume":"80","author":"Barakat","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.annonc.a059312","article-title":"Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients","volume":"6","author":"Chang","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.bjc.6600770","article-title":"Carcinosarcoma of the ovary","volume":"88","author":"Harris","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2007.09.003_bib9","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1097-0142(19951001)76:7<1209::AID-CNCR2820760717>3.0.CO;2-V","article-title":"Malignant mixed mullerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy","volume":"76","author":"Muntz","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2007.09.003_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2559.2000.01015.x","article-title":"Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases","volume":"37","author":"Ariyoshi","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2007.09.003_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/gyno.2002.6645","article-title":"Paclitaxel and platinum chemotherapy for malignant mixed mullerian tumors of the ovary","volume":"85","author":"Duska","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.0.CO;2-4","article-title":"Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction","volume":"82","author":"Sood","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2007.09.003_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0090-8258(90)90341-H","article-title":"Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin and cisplatin-based chemotherapy","volume":"37","author":"Plaxe","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0090-8258(87)90272-1","article-title":"Ovarian sarcoma","volume":"26","author":"Anderson","year":"1987","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2004.01.007","article-title":"Gynecologic Oncology Group. Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study","volume":"93","author":"Tate Thigpen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2005.07.119","article-title":"Carcinosarcoma of the ovary\u2014a case series","volume":"100","author":"Rutledge","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00000421-198602000-00007","article-title":"Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary: a Gynecologic Oncology Group study","volume":"9","author":"Morrow","year":"1986","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/gyno.1994.1081","article-title":"A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group Study","volume":"53","author":"Sutton","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.2000.5956","article-title":"Chemotherapy for malignant mixed mullerian tumors of the ovary","volume":"79","author":"Sit","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ygyno.2006.12.023","article-title":"A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary","volume":"105","author":"Crotzer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2007.01.037","article-title":"Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience","volume":"105","author":"Leiser","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib22","unstructured":"Silasi D-A, Illuzzi JL, Kelly MG, Rutherford TJ, Mor G, Azodi M, et al.Carcinosarcoma of the ovary. Int J Gynecol Cancer in press."},{"key":"10.1016\/j.ygyno.2007.09.003_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1525-1438.1999.99035.x","article-title":"Malignant mixed m\u00fcllerian tumors of the ovary: histopathologic and clinical review of 36 cases","volume":"9","author":"Hellstr\u00f6m","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2007.09.003_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.0004-8666.2003.00003.x","article-title":"Malignant mixed mullerian tumour of the ovary: prognostic factor and response of adjuvant platinum-based chemotherapy","volume":"43","author":"Inthasorn","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2007.09.003_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jso.2930590112","article-title":"Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary","volume":"59","author":"Geisler","year":"1995","journal-title":"J Surg Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807007238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807007238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T19:41:47Z","timestamp":1556912507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807007238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0090825807007238"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.09.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}